Financial Performance Highlights (Q1FY27 Standalone)

  • Total Revenues: ₹25.09 crore, representing 388.13% year-over-year growth
  • EBITDA: ₹2.07 crore, representing 233.87% year-over-year growth
  • EBITDA Margin: 8.25%, representing 381 basis points year-over-year decline
  • Net Profit: ₹1.23 crore, representing 412.50% year-over-year growth
  • Net Profit Margin: 4.90%, representing 23 basis points year-over-year growth

Orders Announced in FY27

1. Order from New York-based company for supply of body care products totaling ₹2.93 lakhs

2. Order from Indian FMCG company for skincare products totaling ₹1,824.40 lakhs

3. Order from India's leading retail pharmacy and healthcare company totaling ₹1.11 lakhs

4. Sample order worth ₹15.74 lakhs for supply of Gripe Water from established buyer based in Sudan - marks company's first strategic entry into Sudan market

Key Business Developments

  • Received USFDA clearance enabling exports of OTC drug products to USA and access to other international markets
  • Discussions with major Russian group for oral care exports have entered advanced stage
  • Completed onboarding of Ayuveer products on Myntra platform, expanding e-commerce presence to include Amazon, Flipkart, Nykaa, Glowroad, Jiomart, and Myntra
  • Commenced production at new facility with in-house plastic molding for packaging and backward integration
  • Company describes itself as "India's one of the fastest growing and only Vegan Ayurvedic & Herbal Cosmetic Listed company"

Financial Guidance

  • FY2026-27: Expecting Total Income of ₹105 crores with PAT of minimum ₹5-6 crores
  • FY2027-28: Expecting Total Income of ₹156 crores with PAT of minimum ₹9-10 crores

Strategic Initiatives

  • Company is working toward scaling manufacturing and export operations for medical device category products in U.S. market
  • Advanced stages of talks with one of India's largest hotel amenities supplier having Indo-Canadian joint venture
  • Company positioned as one of few small-cap companies with USFDA-approved plant clearance

Management Commentary

Mr. Bhavin Shah, Managing Director, commented on the Q1 performance: "I am delighted with the progress we have made in Q1FY27 by reporting Highest ever Quarterly Total Income of ₹25.09 crore, driven by our consistent focus on expanding our international footprint and strengthening our domestic presence. The growth in our Export Sales and the addition of new product categories have significantly bolstered our position in the global and local markets."

Forward-Looking Statements Disclaimer

The document contains forward-looking statements subject to risks and uncertainties including government actions, local/political/economic developments, technological risks, and other factors that could cause actual results to differ materially. Company undertakes no obligation to update these statements.